These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27231136)

  • 1. Hyperthermia and Severe Rhabdomyolysis From Synthetic Cannabinoids Am J Emerg Med 2016;34:121.e1-2. Doi: 10.1016/j.Ajem.2015.05.052. Epub 2015 Jun 12.
    Su M; Laskowski L; Hoffman RS
    Am J Emerg Med; 2016 Aug; 34(8):1690. PubMed ID: 27231136
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperthermia , Rhabdomyolysis and Synthetic Cannabinoids - the authors respond.
    Hassen GW; Kalantari H
    Am J Emerg Med; 2016 Aug; 34(8):1691. PubMed ID: 27238851
    [No Abstract]   [Full Text] [Related]  

  • 3. Hyperthermia and severe rhabdomyolysis from synthetic cannabinoids.
    Sweeney B; Talebi S; Toro D; Gonzalez K; Menoscal JP; Shaw R; Hassen GW
    Am J Emerg Med; 2016 Jan; 34(1):121.e1-2. PubMed ID: 26143311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel synthetic cannabinoid (Cumyl-4-cyano-BINACA) resulting in hyperthermia, rhabdomyolysis, and renal failure in a 29-year-old patient: it's not meningitis
    El Zahran T; Gerona R; Morgan BW; Pomerleau AC
    Clin Toxicol (Phila); 2019 Jun; 57(6):421-422. PubMed ID: 30442067
    [No Abstract]   [Full Text] [Related]  

  • 5. A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids.
    Hopkins CY; Gilchrist BL
    J Emerg Med; 2013 Oct; 45(4):544-6. PubMed ID: 23890687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum to "A role of the endothelial nitric oxide system in acute renal colic caused by ureteral stone" [Am J Emerg Med. 2018 Feb;36(2):266-270. doi: 10.1016/j.ajem.2017.08.008. Epub 2017 Aug 7].
    Bulbul E; Sener EF; Gunay NE; Taslidere B; Taslidere E; Koyuncu S; Gunay N
    Am J Emerg Med; 2019 May; 37(5):1008. PubMed ID: 30528049
    [No Abstract]   [Full Text] [Related]  

  • 7. Case Series of Synthetic Cannabinoid Intoxication from One Toxicology Center.
    Katz KD; Leonetti AL; Bailey BC; Surmaitis RM; Eustice ER; Kacinko S; Wheatley SM
    West J Emerg Med; 2016 May; 17(3):290-4. PubMed ID: 27330661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic cannabinoid hyperemesis resulting in rhabdomyolysis and acute renal failure.
    Argamany JR; Reveles KR; Duhon B
    Am J Emerg Med; 2016 Apr; 34(4):765.e1-2. PubMed ID: 26422191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychosis and severe rhabdomyolysis associated with synthetic cannabinoid use: A case report.
    Durand D; Delgado LL; de la Parra-Pellot DM; Nichols-Vinueza D
    Clin Schizophr Relat Psychoses; 2015 Jan; 8(4):205-8. PubMed ID: 23518784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Laboratory Studies on Cannabinoids and Psychosis.
    Sherif M; Radhakrishnan R; D'Souza DC; Ranganathan M
    Biol Psychiatry; 2016 Apr; 79(7):526-38. PubMed ID: 26970363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rhabdomyolysis syndrome and hyperthermia secondary to cocaine and/or ecstasy consumption. Report of 2 new cases and review of the problem].
    Vallina Alvarez E; Suárez Arias R; García Diez A; Arribas Castrillo JM
    An Med Interna; 2002 Feb; 19(2):85-8. PubMed ID: 11989105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic Cannabinoid Receptor Agonists: a heterogeneous class of novel psychoactive substance with emerging risk of psychosis.
    Whiting D
    Evid Based Ment Health; 2015 Nov; 18(4):110. PubMed ID: 26363038
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemorrhagic stroke following use of the synthetic marijuana "spice".
    Rose DZ; Guerrero WR; Mokin MV; Gooch CL; Bozeman AC; Pearson JM; Burgin WS
    Neurology; 2015 Sep; 85(13):1177-9. PubMed ID: 26320200
    [No Abstract]   [Full Text] [Related]  

  • 14. ["Spice"--synthetic cannabinoids with dangerous effects].
    Personne M; Westerbergh J; Hammer-Pettersen L
    Lakartidningen; 2014 Nov; 111(47):2105-7. PubMed ID: 25386644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.
    Davis MP
    Expert Opin Investig Drugs; 2014 Aug; 23(8):1123-40. PubMed ID: 24836296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Succinylcholine Induced Rhabdomyolysis in a Heavy Marijuana Smoker: A Case Report.
    Shenfeld I; Nativ H; Avital S
    Isr Med Assoc J; 2022 Oct; 24(10):687-688. PubMed ID: 36309869
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyperthermia and rhabdomyolysis in an adolescent treated with topiramate and olanzapine.
    Strawn JR; Adler CM; Strakowski SM; DelBello MP
    J Child Adolesc Psychopharmacol; 2008 Feb; 18(1):116-8. PubMed ID: 18294095
    [No Abstract]   [Full Text] [Related]  

  • 18. [Severe rhabdomyolysis and intracranial hemorrhage associated with synthetic cannabinoid: a case report].
    Tanei T; Morita Y; Yashima A; Wakita H; Takebayashi S; Nakahara N; Wakabayashi T
    No Shinkei Geka; 2014 Sep; 42(9):867-71. PubMed ID: 25179201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic Cannabinoids.
    Mills B; Yepes A; Nugent K
    Am J Med Sci; 2015 Jul; 350(1):59-62. PubMed ID: 26132518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects.
    van Amsterdam J; Brunt T; van den Brink W
    J Psychopharmacol; 2015 Mar; 29(3):254-63. PubMed ID: 25586398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.